CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. CardioGenics shares last traded at $0.00, with a volume of 0 shares changing hands.
CardioGenics Stock Performance
About CardioGenics
CardioGenics is a healthcare technology company focused on developing diagnostic products for the immunoassay market. Its technology is designed to support the detection and measurement of biological markers used in the diagnosis and management of medical conditions.
The company’s principal platform is the QL Care system, a point-of-care testing technology that combines an analyzer with disposable test cartridges. The platform is intended to provide quantitative immunoassay results in settings such as physician offices, clinics and other near-patient care environments.
Further Reading
- Five stocks we like better than CardioGenics
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
